NASDAQ:TCRT
Alaunos Therapeutics, Inc. Stock News
$1.09
+0.0400 (+3.81%)
At Close: May 31, 2024
Alaunos Therapeutics, Inc. (TCRT) CEO Kevin Boyle on Q2 2022 Results - Earnings Call Transcript
12:01pm, Monday, 15'th Aug 2022
Alaunos Therapeutics, Inc. (NASDAQ:TCRT ) Q2 2022 Earnings Conference Call August 15, 2022 8:30 AM ET Company Participants Danielle Dudgeon - Stern Investor Relations Kevin Boyle - Chief Executive Off
Alaunos Therapeutics to Report Second Quarter 2022 Financial Results on August 15, 2022
08:50am, Monday, 08'th Aug 2022
HOUSTON, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), today announced that it will report financial results for the second quarter
Best Penny Stocks For July 2022? 5 To Watch Right Now
12:30pm, Tuesday, 28'th Jun 2022
Penny stocks to watch right now. The post Best Penny Stocks For July 2022?
Penny Stocks To Buy Now? 4 Biotech Stocks To Watch Before July 2022
11:21am, Friday, 24'th Jun 2022
Biotech penny stocks to watch right now. The post Penny Stocks To Buy Now?
Check These 3 Penny Stocks Out in Mid-June 2022
08:14pm, Wednesday, 08'th Jun 2022
Are these penny stocks on your watchlist right now? The post Check These 3 Penny Stocks Out in Mid-June 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Alaunos Therapeutics to Present at the Jefferies Healthcare Conference
08:30am, Wednesday, 01'st Jun 2022
HOUSTON, June 01, 2022 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a clinical-stage oncology-focused cell therapy company today announced that K
HOUSTON, May 26, 2022 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a clinical-stage oncology-focused cell therapy company today announced a Trial
Alaunos Therapeutics, Inc. (TCRT) CEO Kevin Boyle on Q1 2022 Results - Earnings Call Transcript
12:31pm, Monday, 16'th May 2022
Alaunos Therapeutics, Inc. (NASDAQ:TCRT ) Q1 2022 Earnings Conference Call May 16, 2022 8:30 AM ET Company Participants Alex Lobo - Stern, Investor Relations Kevin Boyle - Chief Executive Officer Drew
Alaunos Therapeutics to Present at the H.C. Wainwright Global Investment Conference
08:30am, Tuesday, 10'th May 2022
HOUSTON, May 10, 2022 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a clinical-stage oncology-focused cell therapy company today announced that Ke
Alaunos Therapeutics to Report First Quarter 2022 Financial Results on May 16, 2022
08:30am, Monday, 09'th May 2022
HOUSTON, May 09, 2022 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), today announced that it will report financial results for the first quarter en
Penny Stocks With Huge Potential According To 4 Wall Street Analysts
11:05am, Wednesday, 04'th May 2022
Penny stocks with huge potential according to analysts in 2022. The post Penny Stocks With Huge Potential According To 4 Wall Street Analysts appeared first on Penny Stocks to Buy, Picks, News and Inf
What Makes Ziopharm (TCRT) a New Buy Stock
01:33pm, Tuesday, 03'rd May 2022
Ziopharm (TCRT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Penny Stocks To Buy? 8 Short Squeeze Stocks To Watch Now
11:27am, Thursday, 21'st Apr 2022
Short squeeze penny stocks to watch. The post Penny Stocks To Buy?
Alaunos Therapeutics, Inc. (TCRT) Kevin Boyle on Q4 2021 Results - Earnings Call Transcript
11:38am, Wednesday, 30'th Mar 2022
Alaunos Therapeutics, Inc. (TCRT) Kevin Boyle on Q4 2021 Results - Earnings Call Transcript
Alaunos Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results on March 30, 2022
08:30am, Wednesday, 16'th Mar 2022
HOUSTON, March 16, 2022 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), today announced that it will report financial results for the fourth quarter
